This application is a National Stage entry of International Application No. PCT/EP2017/062731, filed May 26, 2017, which claims priority to European Patent Application No. 16173126.0, filed Jun. 6, 2016.
The present invention relates to a novel process for producing known heterocyclic compounds of formula I.
The production of unsaturated, heterocyclic compounds by alkylation of unsubstituted ring-member atoms which may be performed inter alia in alcohol (EP 0 259 738) or in only partially water-miscible alcohols (and EP1 252 159) is known.
EP 1024140 describes the reaction of compounds of formula (II)
with 2-chloro-5-chloromethylpyridine in the presence of protic solvents
Protic solvents proposed include in particular alcohols. The addition of phase transfer catalysts such as tetrabutylammonium bromide is also mentioned. However, reported example 2 (page 5) in EP 1024140 achieves only 72% of theory of the product which is much too low for a process on a large industrial scale.
Thus, in all these cases the yield achieved is only unsatisfactory. A subsequent purification of the product is therefore necessary to achieve sufficient purity and therefore very costly.
There is therefore an urgent need for an improved process which makes it possible to produce the desired product of formula I in an industrially easily performable manner but higher yields.
One aspect of the present invention relates to a process for producing compounds of formula (I)
One preferred embodiment relates to a process according to the invention, wherein the phase transfer catalyst is an ammonium salt of formula
One preferred embodiment relates to a process according to the invention, where the organically soluble quaternary ammonium salt is aliquat 336 (methyl-tri-n-octylammonium chloride).
One preferred embodiment relates to a process according to the invention in which the solvent is selected from benzene, toluene, xylene, mixtures thereof or hexane, cyclohexane, methylcyclohexane and mixtures thereof.
One preferred embodiment relates to a process according to the invention, wherein the solvent is toluene.
One preferred embodiment relates to a process according to the invention, wherein M+ is an Na+ ion.
One preferred embodiment relates to a process according to the invention, wherein the compound of formula (I) is the compound of formula (Ia)
It is apparent to those skilled in the art that all embodiments described herein may be combined with one another but it will be appreciated that combinations contrary to the laws of physics are excluded.
It has now been found that, surprisingly, it is precisely the use of nonpolar solvents such as aliphatic or aromatic hydrocarbons and the use of a suitable phase transfer catalyst that can achieve a markedly better yield.
Compounds of Formula (I)
Surprisingly, the process according to the invention makes it possible to produce the abovementioned compounds in a simpler manner, i.e. in a smaller number of process steps and in substantially better yields.
In one preferred embodiment in general formulae (I) and (II) and (IIa) the variables (provided they appear in one of the three formulae) are as follows
A very particularly preferred embodiment is directed to a process for producing a compound of formula (Ia),
Preferred inorganic bases are ammonium-containing bases or aqueous alkali metal or alkaline earth metal hydroxide solutions; particular preference is given to NaOH.
Solvents which may be employed include all nonpolar aliphatic or aromatic solvents or mixtures thereof.
Aromatic solvents used by way of example include:
Particular preference is given to toluene.
To improve conversions and yields, phase transfer catalysts are additionally used such as for example
wherein R4,R5,R6 stand for hydrogen or a C1-C12-alkyl group or -benzyl or -alkylbenzyl (methyl-N(R4, R5, R6)+ anion−,
or
wherein R4, R5, R6 stand for hydrogen or a C1-C12-alkyl group or -benzyl or -alkylbenzyl and R7 stands for a C1-C12-alkyl group or -benzyl or -alkylbenzyl, preferably for a C1-C12-alkyl group,
and anion− stands for OH, chloride, bromide, iodide, or cyanide, particularly preferably for chloride.
Especially preferred phase transfer catalysts are organically soluble quaternary ammonium salts, particularly preferably quaternary C1-C12-alkylammonium halogen salts, particularly preferably t C1-C12-alkylammonium chloride salts such as Aliquat 336 (methyl-tri-n-octylammonium chloride).
When water is present the process is performed in a pH range between 6 and 14. It is preferable when the range is between pH 10 and pH 13.
The reaction may be performed at temperatures from 10° C. to 130° C. such as 15° C. to 130° C., optionally under vacuum or under pressure. 40° C. to 80° C. is preferred.
The reaction is advantageously performed under atmospheric pressure but it is also possible to work under reduced or elevated pressure.
Performing the process in practice involves for example reacting 1 mol of 2-chloro-5-chloromethylpyridine with 0.95 to 3 mol of the compounds of formula (II), preferably 1.0 to approximately 2.5 mol, in a solvent such as toluene, preferably in the presence of a catalyst such as a methytrioctylammonium chloride (Aliquat 336).
When using water in a biphasic system the process is preferably operated at pH 8-13.
The reaction time is between 0.1 and 12 hours, preferably 1 to 5 hours.
Once the reaction is complete the product may be isolated by simple cooling below the reaction temperature, for example to 10° C. or less, such as in the range from −10° C. to 10° C., in the range from 0° C. to 10° C. or below 10° C. such as in the range from 0° C. to 9° C., and filtration.
It is alternatively possible to initially separate the phases. Separation of the organic phase is effected at 50° C. to 120° C., preferably at 40° C. to 80° C. The mixture is then cooled as described above and the precipitated active substance is isolated, washed and optionally recrystallized.
The compounds of formula (I) are suitable for use as insecticides for example (EP A2 0235 752, EP A2 0259 738).
The examples which follow illustrate the subject matter of the invention without limiting it in any way.
0.501 mol of CCMP (2-chloro-5-chloromethylpyridine) were initially charged in 260 g of toluene together with 5 g of aliquat 336 (methyl-tri-n-octylammonium chloride) and heated to 70° C. Over 1 h, 250 g of a 29.8% strength solution of 2-cyaniminothiazolidine sodium salt (0.5 mol) in water were metered in. Stirring was then continued until complete conversion of the cyaniminothiazolidine. The batch was then cooled to 10° C. and filtered.
The obtained solid was then washed twice with respective 70 g portions of toluene chilled to 10° C. After drying under vacuum 119 g of the 98.5% pure active substance were thus obtained (92.5% of theory, smp 136-137° C.).
12 mol of CCMP (2-chloro-5-chloromethylpyridine) were initially charged in 1207 g of toluene together with 71 g of aliquat 336 (methyl-tri-n-octylammonium chloride) and heated to 60° C. Over 2 h, 11.6 mol of a 29.8% strength solution of 2-cyaniminothiazolidine sodium salt in water were metered in. Stirring was then continued until complete conversion of the cyaniminothiazolidine. The batch was then cooled to 10° C. and filtered.
The obtained solid was then washed once with 1600 g of toluene chilled to 10° C. and 2000 g of water. After drying under vacuum 2820 g of the 99.8% pure active substance were thus obtained (95% of theory).
0.501 mol of CCMP (2-chloro-5-chloromethylpyridine) were initially charged in 260 g of 1-butanol together with 5 g of aliquat 336 (methyl-tri-n-octylammonium chloride) and heated to 70° C. Over one hour, 250 g of a 29.8% strength solution of 2-cyaniminothiazolidine sodium salt (0.5 mol) in water were metered in. Stirring was then continued until complete conversion of the cyaniminothiazolidine. The batch was then cooled to 10° C. and filtered.
The obtained solid was then washed twice with respective 70 g portions of 1-butanol/toluene (1:1 mixture) chilled to 10° C. After drying under vacuum 88.1 g of the 97.8% pure active substance were thus obtained (68.2% of theory).
0.615 mol of potassium carbonate and 0.3 mol of 2-cyaniminothiazolidine were suspended in 100 ml of n-butanol and stirred at 60° C. for 1 h. Over 2 h, at 70° C., 0.315 mol of 2-chloro-5-chloromethylpyridine/2-chloro-5-methylpyridine (CCMP/CMP, 23% CCMP in the mixture) suspended in 100 ml of n-butanol were added and stirred for 2 h at 72° C. After cooling to 65° C., 400 g of water were then added and the phases separated. The organic phase was then stirred for 3 h at 50° C. and then stirred for 18 h at 5° C. Precipitated product was filtered off and dried; 59.6 g (78% of theory).
0.3 mol of 2-cyaniminothiazolidine and 4.2 g of tetrabutylammonium bromide were suspended in 300 ml of water and heated to 70° C. This was followed by addition of 0.315 mol of CMP/CCMP mixture. The pH of the reaction mixture was continuously held with NaOH at 8 to 8.5. After 2 hours of reaction time at 60° C. a phase separation was then performed at this temperature and the organic phase was diluted with 150 ml of butanol and stirred. The mixture was cooled to 3° C. over 3 h and precipitated product suctioned off; 58.5 g (76% of theory) were thus obtained.
Number | Date | Country | Kind |
---|---|---|---|
16173126 | Jun 2016 | EP | regional |
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/EP2017/062731 | 5/26/2017 | WO | 00 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2017/211594 | 12/14/2017 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
4803277 | Shiokawa et al. | Feb 1989 | A |
4849432 | Shiokawa et al. | Jul 1989 | A |
4882344 | Shiokawa et al. | Nov 1989 | A |
4988712 | Shiokawa et al. | Jan 1991 | A |
6211379 | Seifert et al. | Apr 2001 | B1 |
6667401 | Seifert et al. | Dec 2003 | B2 |
20190152933 | Kulkarni et al. | May 2019 | A1 |
20200347024 | Kulkarni et al. | Nov 2020 | A1 |
Number | Date | Country |
---|---|---|
1401646 | Mar 2003 | CN |
0235725 | Sep 1987 | EP |
0235752 | Sep 1987 | EP |
0259738 | Mar 1988 | EP |
1024140 | Aug 2000 | EP |
1252159 | Oct 2002 | EP |
0153296 | Jul 2001 | WO |
2017048628 | Mar 2017 | WO |
Entry |
---|
PCT International Search Report for PCT/EP2017/062731, dated Jul. 31, 2017. |
Number | Date | Country | |
---|---|---|---|
20210261536 A1 | Aug 2021 | US |